Johnson & Johnson Reaches Agreement On Risperdal Misdemeanor Charge

10.08.2011 - Healthcare giant Johnson & Johnson has reached an agreement to settle a single misdemeanor charge related to its antipsychotic treatment Risperdal, the company said in a regulatory...